Efficacy and safety of enoxaparin compared with unfractionated heparin in the pharmacoinvasive management of acute ST-segment elevation myocardial infarction: Insights from the TRANSFER-AMI trial

American Heart Journal

Volumn 163, Issue 2, 2012, Pages

  Lavi, Shahar ^a,b   Cantor, Warren J ^c,d   Casanova, Amparo ^d   Tan, Mary K ^e   Yan, Andrew T ^d,e,f   Džavík, Vladimír ^d,g   Fitchett, David ^d,f   Cohen, Eric A ^d,h   Borgundvaag, Bjug ^d,i   Heffernan, Michael ^j   Ducas, John ^k,l   Goodman, Shaun G ^d,e,f  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e CANADIAN HEART RESEARCH CENTRE   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g UNIVERSITY HEALTH NETWORK   (Canada)

^h SUNNYBROOK RESEARCH INSTITUTE   (Canada)

ⁱ MOUNT SINAI HOSPITAL   (Canada)

^j Halton Healthcare Services   (Canada)

^k ST BONIFACE GENERAL HOSPITAL   (Canada)

^l UNIVERSITY OF MANITOBA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBRINOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 84856551644     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.10.015     Document Type: Article

References (25)

1. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20 (Pubitemid 36050955)
2. C.M. Gibson, Y.B. Pride, and P.D. Frederick Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006 Am Heart J 156 2008 1035 1044
3. E.M. Antman, D.T. Anbe, and P.W. Armstrong ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction) Circulation 110 2004 e82 e292
4. E.M. Antman, D.A. Morrow, and C.H. McCabe Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction N Engl J Med 354 2006 1477 1488
5. F. Van de Werf, J. Bax, and A. Betriu Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
6. G. Montalescot, S.G. Ellis, and M.A. de Belder Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events) JACC 3 2010 203 212
7. G. Montalescot, U. Zeymer, and J. Silvain Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial Lancet 378 2011 693 703
8. C.M. Gibson, S.A. Murphy, and G. Montalescot Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial J Am Coll Cardiol 49 2007 2238 2246 (Pubitemid 46856824)
9. W.J. Cantor, D. Fitchett, and B. Borgundvaag Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) Am Heart J 155 2008 19 25 (Pubitemid 350237678)
10. W.J. Cantor, J. Burnstein, and R. Choi Transfer for urgent percutaneous coronary intervention early after thrombolysis for ST-elevation myocardial infarction: the TRANSFER-AMI pilot feasibility study Can J Cardiol 22 2006 1121 1126 (Pubitemid 44970044)
11. W.J. Cantor, D. Fitchett, and B. Borgundvaag Routine early angioplasty after fibrinolysis for acute myocardial infarction N Engl J Med 360 2009 2705 2718
12. L. Wallentin, P. Goldstein, and P.W. Armstrong Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction Circulation 108 2003 135 142 (Pubitemid 36871293)
13. C.B. Granger, R.J. Goldberg, and O. Dabbous Predictors of hospital mortality in the Global Registry of Acute Coronary Events Arch Intern Med 163 2003 2345 2353 (Pubitemid 37310196)
14. P.R. Rosenbaum, and D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrica 70 1983 41 55
15. G. Montalescot, H.D. White, and R. Gallo Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention N Engl J Med 355 2006 1006 1017 (Pubitemid 44343544)
16. R. Dumaine, M. Borentain, and O. Bertel Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials Arch Intern Med 167 2007 2423 2430 (Pubitemid 350258448)
17. P.R. Eisenberg Role of heparin in coronary thrombolysis Chest 101 4 Suppl 1992 131S 139S
18. F.W. Verheugt, A. Meijer, and W.K. Lagrand Reocclusion: the flip side of coronary thrombolysis J Am Coll Cardiol 27 1996 766 773 (Pubitemid 26104854)
19. American College of Cardiology/American Heart Association Task Force on Practice G, Developed in Collaboration With the Canadian Cardiovascular S, Endorsed by the American Academy of Family P, Writing Group to Review New Evidence and Update the Acc/Aha Guidelines for the Management of Patients With St-Elevation Myocardial Infarction WoBotWC E.M/ Antman, and M. M 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction J Am Coll Cardiol 51 2008 210 247
20. U. Zeymer, A. Gitt, and C. Junger Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarction Thromb Haemost 99 2008 150 154
21. S.G. Ellis, M. Tendera, and M.A. de Belder Facilitated PCI in patients with ST-elevation myocardial infarction N Engl J Med 358 2008 2205 2217 (Pubitemid 351724450)
22. F. Borgia, S.G. Goodman, and S. Halvorsen Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis Eur Heart J 31 2011 2156 2169
23. J.J. Ferguson, R.M. Califf, and E.M. Antman Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial JAMA 292 2004 45 54
24. M. Cohen, K.W. Mahaffey, and K. Pieper A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes J Am Coll Cardiol 48 2006 1346 1354 (Pubitemid 44436804)
25. L. Drouet, C. Bal dit Sollier, and J. Martin Adding intravenous unfractionated heparin to standard enoxaparin causes excessive anticoagulation not detected by activated clotting time: results of the STACK-on to ENOXaparin (STACKENOX) study Am Heart J 158 2009 177 184